On July 27, 2022, Humana Inc. announced that Timothy Alan Wheatley, Segment President, Retail, will be transitioning from his current role as of December 31, 2022, after which he has agreed to serve in an advisory capacity to the Company through March 1, 2024 ("the Transition Period") to ensure a smooth transition of the Company's Retail Segment operations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
320.5 USD | -0.14% | +4.79% | -29.98% |
02/05 | Cigna sees strong annual profit on lower costs, pharmacy benefit strength | RE |
26/04 | Deutsche Bank Adjusts Price Target on Humana to $341 From $355 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.98% | 38.63B | |
-6.46% | 453B | |
+11.75% | 122B | |
+14.04% | 96.87B | |
+0.81% | 39.92B | |
-5.99% | 19.91B | |
-14.69% | 3.05B | |
-23.00% | 1.26B | |
-27.00% | 345M |
- Stock Market
- Equities
- HUM Stock
- News Humana Inc.
- Humana Inc. Announces Transition of Timothy Alan Wheatley, Segment President, Retail to Advisor